Bank of New York Mellon’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2M | Sell |
494,613
-88,108
| -15% | -$3.24M | ﹤0.01% | 1567 |
|
|
2025
Q1 | $20.6M | Buy |
582,721
+13,706
| +2% | +$485K | ﹤0.01% | 1485 |
|
|
2024
Q4 | $24.9M | Buy |
569,015
+36,705
| +7% | +$1.61M | ﹤0.01% | 1441 |
|
|
2024
Q3 | $24.1M | Sell |
532,310
-112,943
| -18% | -$5.12M | ﹤0.01% | 1466 |
|
|
2024
Q2 | $25M | Buy |
645,253
+115,844
| +22% | +$4.5M | ﹤0.01% | 1444 |
|
|
2024
Q1 | $17.1M | Sell |
529,409
-51,807
| -9% | -$1.67M | ﹤0.01% | 1663 |
|
|
2023
Q4 | $16.7M | Buy |
581,216
+160,850
| +38% | +$4.61M | ﹤0.01% | 1694 |
|
|
2023
Q3 | $11.6M | Buy |
420,366
+8,825
| +2% | +$244K | ﹤0.01% | 1858 |
|
|
2023
Q2 | $11M | Buy |
411,541
+118,930
| +41% | +$3.18M | ﹤0.01% | 1905 |
|
|
2023
Q1 | $6.34M | Buy |
292,611
+33,343
| +13% | +$722K | ﹤0.01% | 2168 |
|
|
2022
Q4 | $6.18M | Buy |
259,268
+1,403
| +0.5% | +$33.4K | ﹤0.01% | 2208 |
|
|
2022
Q3 | $5.09M | Buy |
257,865
+59,854
| +30% | +$1.18M | ﹤0.01% | 2278 |
|
|
2022
Q2 | $3.86M | Sell |
198,011
-63,797
| -24% | -$1.24M | ﹤0.01% | 2462 |
|
|
2022
Q1 | $6.68M | Sell |
261,808
-6,749
| -3% | -$172K | ﹤0.01% | 2273 |
|
|
2021
Q4 | $6.76M | Buy |
268,557
+342
| +0.1% | +$8.61K | ﹤0.01% | 2307 |
|
|
2021
Q3 | $7.38M | Buy |
268,215
+35,981
| +15% | +$990K | ﹤0.01% | 2289 |
|
|
2021
Q2 | $7.37M | Buy |
232,234
+90,332
| +64% | +$2.87M | ﹤0.01% | 2289 |
|
|
2021
Q1 | $6.51M | Buy |
141,902
+4,493
| +3% | +$206K | ﹤0.01% | 2322 |
|
|
2020
Q4 | $5.44M | Buy |
137,409
+8,049
| +6% | +$319K | ﹤0.01% | 2317 |
|
|
2020
Q3 | $4.5M | Buy |
129,360
+73,404
| +131% | +$2.55M | ﹤0.01% | 2270 |
|
|
2020
Q2 | $1.77M | Buy |
55,956
+16,888
| +43% | +$533K | ﹤0.01% | 2756 |
|
|
2020
Q1 | $856K | Buy |
+39,068
| New | +$856K | ﹤0.01% | 3084 |
|